Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:30 am Purchase |
2024-12-31 | 13G | Vera Therapeutics, Inc. VERA |
AVORO CAPITAL ADVISORS LLC | 5,610,000 8.900% |
1,300,410 (+30.17%) |
Filing History |
| 2024-11-14 4:10 pm Sale |
2024-09-30 | 13G | Vera Therapeutics, Inc. VERA |
Commodore Capital LP | 2,475,000 4.500% |
-1,425,000 (-36.54%) |
Filing History |
| 2024-11-14 4:05 pm Sale |
2024-02-29 | 13G | Vera Therapeutics, Inc. VERA |
Commodore Capital LP | 3,900,000 7.300% |
-1,550,000 (-28.44%) |
Filing History |
| 2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Vera Therapeutics, Inc. VERA |
PRICE T ROWE ASSOCIATES INC | 3,939,109 7.200% |
3,939,109 (New Position) |
Filing History |
| 2024-11-14 12:15 pm Sale |
2024-09-30 | 13G | Vera Therapeutics, Inc. VERA |
Kynam Capital Management, LP | 1,576,549 2.490% |
-2,073,790 (-56.81%) |
Filing History |
| 2024-11-14 09:35 am Purchase |
2024-09-30 | 13G | Vera Therapeutics, Inc. VERA |
AVORO CAPITAL ADVISORS LLC | 4,309,590 7.900% |
4,309,590 (New Position) |
Filing History |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | Vera Therapeutics, Inc. VERA |
FMR CORP | 2,785,284 5.080% |
10,912 (+0.39%) |
Filing History |
| 2024-11-04 7:49 pm Purchase |
2024-10-31 | 13D | Vera Therapeutics, Inc. VERA |
Longitude Capital Partners IV LLC | 5,184,062 8.400% |
20,000 (+0.39%) |
Filing History |
| 2024-03-26 7:57 pm Sale |
2024-03-22 | 13D | Vera Therapeutics, Inc. VERA |
Sofinnova Venture Partners X L.P. | 2,813,837 5.400% |
-834,459 (-22.87%) |
Filing History |
| 2024-02-20 7:11 pm Purchase |
2024-01-30 | 13D | Vera Therapeutics, Inc. VERA |
Sofinnova Venture Partners X L.P. | 3,648,296 6.900% |
171,215 (+4.92%) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Citadel Advisors LLC | 43,447 0.100% |
-1,948,106 (-97.82%) |
Filing History |
| 2024-02-14 4:10 pm Purchase |
2023-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Commodore Capital LP | 5,450,000 12.300% |
448,217 (+8.96%) |
Filing History |
| 2024-02-14 4:05 pm Purchase |
2023-06-14 | 13G | Vera Therapeutics, Inc. VERA |
Commodore Capital LP | 5,001,783 11.300% |
2,658,926 (+113.49%) |
Filing History |
| 2024-02-14 3:21 pm Unchanged |
2023-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Ares Trading S.A. | 1,913,501 3.600% |
0 (Unchanged) |
Filing History |
| 2024-02-14 12:49 pm Purchase |
2023-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Kynam Capital Management, LP | 3,650,339 8.220% |
2,241,241 (+159.06%) |
Filing History |
| 2024-02-12 4:38 pm Purchase |
2023-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Woodline Partners LP | 1,140,632 2.200% |
1,140,632 (New Position) |
Filing History |
| 2024-02-09 10:05 am Sale |
2024-02-08 | 13G | Vera Therapeutics, Inc. VERA |
FMR CORP | 2,774,372 6.243% |
-533,238 (-16.12%) |
Filing History |
| 2024-02-05 4:45 pm Purchase |
2024-02-01 | 13D | Vera Therapeutics, Inc. VERA |
Longitude Capital Partners IV LLC | 5,164,062 9.800% |
9,925 (+0.19%) |
Filing History |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Vera Therapeutics, Inc. VERA |
BLACKROCK INC BLK |
2,754,894 6.200% |
2,754,894 (New Position) |
Filing History |
| 2023-11-13 09:02 am Sale |
2023-11-10 | 13G | Vera Therapeutics, Inc. VERA |
FMR CORP | 3,307,610 7.463% |
-841,036 (-20.27%) |
Filing History |